Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

All Drugs Associated with Malignant neoplasm progression (Page 2)

771 drugs have been associated with Malignant neoplasm progression in FAERS reports.

Drug Reports Deaths Hosp. Life-Threat.
ABEMACICLIB 890 152 216 20
TRAMETINIB 807 320 205 48
TEMOZOLOMIDE 779 208 125 21
DENOSUMAB 767 129 141 19
RAMUCIRUMAB 743 343 243 53
LEUCOVORIN 733 204 151 26
CYTARABINE 728 247 174 52
NINTEDANIB 677 375 129 18
IFOSFAMIDE 671 210 120 43
BENDAMUSTINE 664 221 153 32
CETUXIMAB 662 225 172 27
VINORELBINE 624 107 110 17
DASATINIB 613 203 126 29
PREDNISOLONE 599 279 220 41
ERIBULIN 594 228 158 24
TISAGENLECLEUCEL 582 400 126 109
NILOTINIB 581 237 155 34
GEMCITABINE\GEMCITABINE 551 157 104 19
LEUPROLIDE 549 128 72 15
CERITINIB 523 196 156 20
EPIRUBICIN 513 104 63 35
ALPELISIB 497 136 99 13
ABIRATERONE 469 81 57 5
ENFORTUMAB VEDOTIN-EJFV 410 137 79 9
BORTEZOMIB 375 176 115 24
TUCATINIB 361 37 26 2
BICALUTAMIDE 352 52 43 4
LUTETIUM OXODOTREOTIDE LU-177 338 96 93 9
POMALIDOMIDE 324 59 46 6
RUXOLITINIB 321 130 72 11
LANREOTIDE 295 70 135 15
VENETOCLAX 287 121 87 18
ACALABRUTINIB 285 48 31 7
MORPHINE 280 112 164 15
FLUDARABINE 270 87 65 20
IBRUTINIB 259 98 53 3
APIXABAN 251 81 154 3
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN 251 81 47 2
SUNITINIB 242 80 32 7
AXITINIB 241 76 58 9
ATEZOLIZUMAB 238 118 89 10
CABOZANTINIB 238 143 132 25
TOPOTECAN 238 61 26 13
ADO-TRASTUZUMAB EMTANSINE 237 30 49 4
XTANDI 235 110 34 1
PERTUZUMAB 233 45 54 3
ELOTUZUMAB 227 88 77 15
OXYCODONE 222 159 77 12
SORAFENIB 219 65 40 8
AMLODIPINE 211 25 142 5
« 1 2 3 4 5 16 »